Sermonix Pharmaceuticals Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Series A3
- Latest Deal Amount
-
$40M
- Investors
-
5
Sermonix Pharmaceuticals General Information
Description
Developer of pharmaceutical drugs intended to treat ESR1-mutated metastatic breast and gynecological cancers. The company's drugs are used for women's health, menopause, and selective estrogen receptor modulators, enabling cancer patients to get quality oncology products through proof of concept, clinical development, and regulatory approval.
Contact Information
Website
www.sermonixpharma.comCorporate Office
- 250 East Broad Street
- Suite 250
- Columbus, OH 43215
- United States
Corporate Office
- 250 East Broad Street
- Suite 250
- Columbus, OH 43215
- United States
Sermonix Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A3) | 15-Nov-2021 | $40M | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series A1) | 31-Jul-2019 | Completed | Clinical Trials - Phase 2 | |||
| 2. Seed Round | 28-Nov-2017 | $4.2M | $7.9M | Completed | Clinical Trials - Phase 2 | |
| 1. Seed Round | 10-Nov-2016 | $3.7M | $3.7M | Completed | Clinical Trials - Phase 2 |
Sermonix Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 1,998,257 | $0.000100 | 5% | $13.38 | $13.38 | 1x | $13.38 | 35.92% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Sermonix Pharmaceuticals Comparisons
Industry
Financing
Details
Sermonix Pharmaceuticals Competitors (75)
One of Sermonix Pharmaceuticals’s 75 competitors is Crinetics Pharmaceuticals, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Crinetics Pharmaceuticals | Formerly VC-backed | San Diego, CA | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| Altimmune | Formerly VC-backed | Gaithersburg, MD | ||||
| Rein Therapeutics | Formerly VC-backed | Austin, TX |
Sermonix Pharmaceuticals Patents
Sermonix Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026095931-A1 | Neoadjuvant treatment of er+ breast cancer with lasofoxifene | Pending | 30-Oct-2024 | ||
| WO-2026096820-A1 | Neoadjuvant treatment of er+ breast cancer with lasofoxifene | Pending | 30-Oct-2024 | ||
| AU-2025216603-A1 | Lasofoxifene treatment of er+ cancers with constitutively active esr1 mutations | Pending | 30-Jan-2024 | ||
| WO-2025165887-A1 | Lasofoxifene treatment of er+ cancers with constitutively active esr1 mutations | Pending | 30-Jan-2024 | ||
| WO-2025075631-A1 | Lasofoxifene treatment of endocrine therapy resistant er+ cancer | Inactive | 06-Oct-2023 | A61K31/40 |
Sermonix Pharmaceuticals Signals
Sermonix Pharmaceuticals Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Xontogeny | Accelerator/Incubator | Minority | ||
| Angel (individual) | Minority | |||
| Wild Family Office | Family Office | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority |
Sermonix Pharmaceuticals FAQs
-
When was Sermonix Pharmaceuticals founded?
Sermonix Pharmaceuticals was founded in 2014.
-
Where is Sermonix Pharmaceuticals headquartered?
Sermonix Pharmaceuticals is headquartered in Columbus, OH.
-
What is the size of Sermonix Pharmaceuticals?
Sermonix Pharmaceuticals has 11 total employees.
-
What industry is Sermonix Pharmaceuticals in?
Sermonix Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Sermonix Pharmaceuticals a private or public company?
Sermonix Pharmaceuticals is a Private company.
-
What is the current valuation of Sermonix Pharmaceuticals?
The current valuation of Sermonix Pharmaceuticals is .
-
What is Sermonix Pharmaceuticals’s current revenue?
The current revenue for Sermonix Pharmaceuticals is .
-
How much funding has Sermonix Pharmaceuticals raised over time?
Sermonix Pharmaceuticals has raised $73.9M.
-
Who are Sermonix Pharmaceuticals’s investors?
Xontogeny, , Wild Family Office, , and have invested in Sermonix Pharmaceuticals.
-
Who are Sermonix Pharmaceuticals’s competitors?
Crinetics Pharmaceuticals, Genentech, Gilead, Altimmune, and Rein Therapeutics are some of the 75 competitors of Sermonix Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process